Suppr超能文献

胰腺癌适形调强放疗中简化优化器的评估。

Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.

机构信息

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Istituto di Radiologia, Università Cattolica del Sacro Cuore, Roma, Italy.

出版信息

J Appl Clin Med Phys. 2019 Sep;20(9):20-30. doi: 10.1002/acm2.12697. Epub 2019 Aug 24.

Abstract

PURPOSE

Magnetic resonance-guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a MR-Linac treatment planning system (TPS) with those obtained using an advanced optimizer implemented on a conventional Linac.

METHODS

Twenty patients affected by locally advanced pancreatic cancer (LAPC) were considered. Gross tumor volume (GTV) and surrounding organ at risks (OARs) were contoured on the average 4DCT scan. Planning target volume was generated from GTV by adding an isotropic 3 mm margin and excluding overlap areas with OARs. Treatment plans were generated by using the simple optimizer for the MR-Linac in intensity-modulated radiation therapy (IMRT) and the advanced optimizer for conventional Linac in IMRT and volumetric modulated arc therapy (VMAT) technique. Prescription dose was 40 Gy in five fractions. The dosimetric comparison was performed on target coverage, dosimetric indicators, and low dose diffusion.

RESULTS

The simplified optimizer of MR-Linac generated clinically acceptable plans in 80% and optimal plans in 55% of cases. The number of clinically acceptable plans obtained using the advanced optimizer of the conventional Linac with IMRT was the same of MR-Linac, but the percentage of optimal plans was higher (65%). Using the VMAT technique, it is possible to obtain clinically acceptable plan in 95% and optimal plans in 90% of cases. The advanced optimizer combined with VMAT technique ensures higher target dose homogeneity and minor diffusion of low doses, but its actual optimization time is not suitable for MRgART.

CONCLUSION

Simplified optimization solutions implemented in the MR-Linac TPS allows to elaborate in most of cases treatment plans dosimetrically comparable with those obtained by using an advanced optimizer. A superior treatment plan quality is possible using the VMAT technique that could represent a breakthrough for the MRgART if the modern advancements will lead to shorter optimization times.

摘要

目的

磁共振引导自适应放疗(MRgART)被认为是胰腺癌的一种有前途的资源,因为它可以根据每天的解剖结构在线修改剂量分布。本研究旨在比较在 MR 直线加速器治疗计划系统(TPS)上实现的简化优化器与在常规直线加速器上实现的先进优化器获得的剂量学性能。

方法

本研究共纳入 20 例局部晚期胰腺癌(LAPC)患者。在平均 4DCT 扫描上勾画大体肿瘤体积(GTV)和周围危及器官(OARs)。计划靶区(PTV)由 GTV 生成,通过添加各向同性 3mm 边界并排除与 OARs 重叠的区域。使用 MR 直线加速器的简化优化器生成强度调制放疗(IMRT)、常规直线加速器的先进优化器生成 IMRT 和容积调制弧形治疗(VMAT)技术的治疗计划。处方剂量为 40Gy,共 5 次。在靶区覆盖、剂量学指标和低剂量扩散方面进行了剂量学比较。

结果

MR 直线加速器的简化优化器在 80%的情况下生成了临床可接受的计划,在 55%的情况下生成了最佳计划。使用常规直线加速器的先进优化器生成 IMRT 技术的临床可接受计划数量与 MR 直线加速器相同,但最佳计划的比例更高(65%)。使用 VMAT 技术,可以在 95%的情况下获得临床可接受的计划,在 90%的情况下获得最佳计划。先进优化器结合 VMAT 技术可确保更高的靶区剂量均匀性和更低剂量的扩散,但实际优化时间不适合 MRgART。

结论

在 MR 直线加速器 TPS 中实现的简化优化方案允许在大多数情况下制定与使用先进优化器获得的剂量学上可比的治疗计划。使用 VMAT 技术可以获得更好的治疗计划质量,如果现代技术的进步能够缩短优化时间,那么这将是 MRgART 的一个突破。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e542/6753732/98e77ce06339/ACM2-20-20-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验